Not Signed In -
Hypertension |
High Blood Pressure; Hypertension/High Blood Pressure |
Clinical Trial: Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients with Essential Hypertension (Banyu Study)
This study is no longer recruiting patients.
|
Purpose
The purpose of this study is to evaluate antihypertensive (lowering blood pressure) effectiveness of three combinations of approved study drugs compared to both study drugs being given alone.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Hypertension | | Phase IV |
MedlinePlus related topics: High Blood Pressure
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study
Official Title: A Study of the Antihypertensive Efficacy and Safety of a Single Approved Therapy as Compared to Another Single Approved Therapy and to the Combination of Both Approved Drugs in Japanese Patients with Essential Hypertension (Banyu Study)
Eligibility
Ages Eligible for Study: 25 Years - 74 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Japanese ancestry
- Stable high blood pressure defined by the study criteria
Exclusion Criteria:
- Pregnant or nursing
- Significant concurrent kidney, liver, blood, or other disease
- Recent heart attack or heart surgery
- History of stroke, severe hypertension (high blood pressure), significant heart failure or cardiac arrhythmias
- Significant lab abnormalities
- Uncontrolled blood sugar
- History of certain drug allergies
Location Information
Pennsylvania
Call for Information, Horsham, Pennsylvania, 19044, United States
More Information
Record last reviewed: September 2004
Last Updated: October 13, 2004
Record first received: September 21, 2004
ClinicalTrials.gov Identifier: NCT00092209
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 8, 2005
email this page
print this page
bookmark this page
feedback on this page
